Regal Investment Advisors LLC Pfizer Inc Transaction History

Regal Investment Advisors LLC

$1.4 Billion
Q3 2024

A detailed history of Regal Investment Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Regal Investment Advisors LLC holds 319,232 shares of PFE stock, worth $8.16 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares

319,232

Previous 282,398 13.04%

Holding current value

$8.16 Million

Previous $7.9 Million 16.92%

% of portfolio

0.66%

Previous 0.53%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$27.7 - $31.39 $1.02 Million - $1.16 Million	36,834 Added 13.04%	319,232 $9.24 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $482,238 - $565,093	19,091 Added 7.25%	282,398 $7.9 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $1.51 Million - $1.73 Million	58,142 Added 28.34%	263,307 $7.31 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $178,885 - $232,353	-6,846 Reduced 3.23%	205,165 $5.91 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $12,771 - $14,928	-398 Reduced 0.19%	212,011 $7.03 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $327,572 - $378,993	9,069 Added 4.46%	212,409 $7.79 Million
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $450,148 - $586,027	11,428 Added 5.95%	203,340 $8.3 Million
Q4 2022 Mar 01, 2023	BUY	$41.75 - $54.5 $436,412 - $569,688	10,453 Added 5.76%	191,912 $9.84 Million
Q3 2022 Nov 15, 2022	BUY	$43.76 - $53.42 $694,471 - $847,775	15,870 Added 9.58%	181,459 $7.94 Million
Q2 2022 Aug 09, 2022	SELL	$46.53 - $55.17 $512,574 - $607,752	-11,016 Reduced 6.24%	165,589 $8.68 Million
Q1 2022 May 09, 2022	BUY	$45.75 - $56.69 $362,843 - $449,608	7,931 Added 4.7%	176,605 $9.14 Million
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $129,166 - $191,467	-3,126 Reduced 1.82%	168,674 $9.96 Million
Q3 2021 Nov 05, 2021	BUY	$39.25 - $50.42 $1.07 Million - $1.38 Million	27,317 Added 18.91%	171,800 $7.39 Million
Q2 2021 Aug 09, 2021	BUY	$35.91 - $40.68 $5.19 Million - $5.88 Million	144,483 New	144,483 $5.66 Million
Q1 2021 May 12, 2021	SELL	$33.49 - $37.77 $6.03 Million - $6.8 Million	-179,969 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $6.02 Million - $7.66 Million	179,969 New	179,969 $6.63 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $5.51 Million - $6.46 Million	-173,450 Closed	0 $0
Q2 2020 Aug 03, 2020	BUY	$30.12 - $36.54 $5.22 Million - $6.34 Million	173,450 New	173,450 $5.67 Million
Q1 2020 May 12, 2020	SELL	$27.03 - $38.62 $4.48 Million - $6.4 Million	-165,649 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$32.92 - $37.36 $1.72 Million - $1.96 Million	52,337 Added 46.19%	165,649 $6.49 Million
Q3 2019 Nov 15, 2019	SELL	$32.49 - $42.13 $92,726 - $120,239	-2,854 Reduced 2.46%	113,312 $4.07 Million
Q2 2019 Jul 26, 2019	BUY	$36.98 - $41.52 $555,735 - $623,962	15,028 Added 14.86%	116,166 $5.03 Million
Q1 2019 May 09, 2019	BUY	$37.5 - $41.2 $405,637 - $445,660	10,817 Added 11.98%	101,138 $4.3 Million
Q4 2018 Feb 04, 2019	BUY	$38.47 - $43.86 $411,782 - $469,477	10,704 Added 13.44%	90,321 $3.94 Million
Q3 2018 Nov 05, 2018	BUY	$34.47 - $41.81 $1.61 Million - $1.96 Million	46,833 Added 142.85%	79,617 $3.51 Million
Q2 2018 Aug 10, 2018	SELL	$32.98 - $35.16 $1.6 Million - $1.7 Million	-48,492 Reduced 59.66%	32,784 $1.19 Million
Q1 2018 Apr 25, 2018	BUY	$31.91 - $37.02 $181,567 - $210,643	5,690 Added 7.53%	81,276 $2.88 Million
Q4 2017 Feb 06, 2018	BUY	$33.26 - $35.29 $565,486 - $600,000	17,002 Added 29.02%	75,586 $2.74 Million
Q3 2017 Nov 08, 2017	BUY	$31.0 - $34.15 $1.82 Million - $2 Million	58,584	58,584 $2.09 Million

Others Institutions Holding PFE

# of Institutions

3,258

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $143B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regal Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regal Investment Advisors LLC with notifications on news.

Account

Regal Investment Advisors LLC Pfizer Inc Transaction History